Investigator Sponsored Trials (IST) using GE HealthCare Pharmaceutical Diagnostics products

About this program

GE HealthCare Pharmaceutical Diagnostics provides access to investigational and licensed imaging compounds and may offer product supply or reasonable monetary support for Investigator Sponsored Trials (ISTs) that are initiated, designed, and conducted by Principal Investigators who act as both sponsor and investigator. Proposals are reviewed by the GE HealthCare IST Committee (ISTC) for scientific and technical merit, product and funding availability, and alignment with GE HealthCare’s development and medical strategies. Eligible applicants must be qualified PIs responsible for protocol design and study conduct, comply with Good Clinical Practice and local/national regulations, and accept that any support is fair market value and not contingent on commercial commitments.